高钾血症
钾
肾脏疾病
医学
钠
锆
药理学
内科学
材料科学
冶金
出处
期刊:Archives of internal medicine research
[Fortune Journals]
日期:2020-01-01
卷期号:03 (02)
被引量:1
摘要
Sodium polystyrene sulfonate was approved by the FDA in 1958. It was the only potassium binder available on the market until 2015. Patiromer and sodium zirconium cyclosilicate are newly approved potassium binders. They are better tolerated and can be used on a chronic basis to mitigate hyperkalemia. They allow patients to continue to use critical medications such as ACE inhibitors even in advanced chronic kidney disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI